| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |